BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37292214)

  • 1. Corrigendum: The impact of circadian rhythm on Bacillus Calmette-Guérin vaccination effects on SARS-CoV-2 infections.
    Föhse K; Taks EJM; Moorlag SJCFM; Bonten MJM; van Crevel R; Ten Oever J; van Werkhoven CH; Netea MG; van de Maat JS; Hoogerwerf JJ
    Front Immunol; 2023; 14():1208659. PubMed ID: 37292214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of circadian rhythm on Bacillus Calmette-Guérin vaccination effects on SARS-CoV-2 infections.
    Föhse K; Taks EJM; Moorlag SJCFM; Bonten MJM; van Crevel R; Ten Oever J; van Werkhoven CH; Netea MG; van de Maat JS; Hoogerwerf JJ
    Front Immunol; 2023; 14():980711. PubMed ID: 36875134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacillus Calmette-Guérin-induced trained immunity protects against SARS-CoV-2 challenge in K18-hACE2 mice.
    Zhang BZ; Shuai H; Gong HR; Hu JC; Yan B; Yuen TT; Hu YF; Yoon C; Wang XL; Hou Y; Lin X; Huang X; Li R; Au-Yeung YM; Li W; Hu B; Chai Y; Yue M; Cai JP; Ling GS; Hung IF; Yuen KY; Chan JF; Huang JD; Chu H
    JCI Insight; 2022 Jun; 7(11):. PubMed ID: 35446790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
    Charoenlap S; Piromsopa K; Charoenlap C
    Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCG Vaccination of Health Care Workers Does Not Reduce SARS-CoV-2 Infections nor Infection Severity or Duration: a Randomized Placebo-Controlled Trial.
    Claus J; Ten Doesschate T; Gumbs C; van Werkhoven CH; van der Vaart TW; Janssen AB; Smits G; van Binnendijk R; van der Klis F; van Baarle D; Paganelli FL; Leavis H; Verhagen LM; Joosten SA; Bonten MJM; Netea MG; van de Wijgert JHHM;
    mBio; 2023 Apr; 14(2):e0035623. PubMed ID: 36976004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCG vaccination provides protection against IAV but not SARS-CoV-2.
    Kaufmann E; Khan N; Tran KA; Ulndreaj A; Pernet E; Fontes G; Lupien A; Desmeules P; McIntosh F; Abow A; Moorlag SJCFM; Debisarun P; Mossman K; Banerjee A; Karo-Atar D; Sadeghi M; Mubareka S; Vinh DC; King IL; Robbins CS; Behr MA; Netea MG; Joubert P; Divangahi M
    Cell Rep; 2022 Mar; 38(10):110502. PubMed ID: 35235831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.
    White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S
    Front Immunol; 2021; 12():801799. PubMed ID: 35222355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of Bacillus Calmette-Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic.
    Yitbarek K; Abraham G; Girma T; Tilahun T; Woldie M
    Vaccine; 2020 Sep; 38(41):6374-6380. PubMed ID: 32798142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum: Bacillus Calmette-Guérin-Induced Trained Immunity Is Not Protective for Experimental Influenza A/Anhui/1/2013 (H7N9) Infection in Mice.
    de Bree LCJ; Marijnissen RJ; Kel JM; Rosendahl Huber SK; Aaby P; Benn CS; Wijnands MVW; Diavatopoulos DA; van Crevel R; Joosten LAB; Netea MG; Dulos J
    Front Immunol; 2018; 9():2471. PubMed ID: 30393473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of similar epitopes between severe acute respiratory syndrome coronavirus-2 and Bacillus Calmette-Guérin: potential for cross-reactive adaptive immunity.
    Urbán S; Paragi G; Burián K; McLean GR; Virok DP
    Clin Transl Immunology; 2020; 9(12):e1227. PubMed ID: 33318797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin(BCG) vaccine on COVID-19 incidence and mortality - review of the literature.
    Ręka G; Korzeniowska A; Piecewicz-Szczęsna H
    Przegl Epidemiol; 2020; 74(2):290-302. PubMed ID: 33115218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the role of bacillus calmette-guerin vaccination in protection against COVID-19.
    Chauhan A; Singh M; Agarwal A; Jaiswal N; M Lakshmi PV; Singh M
    Int J Mycobacteriol; 2021; 10(4):433-436. PubMed ID: 34916464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacillus Calmette-Guerin Vaccine and Nonspecific Immunity.
    Parmar K; Siddiqui A; Nugent K
    Am J Med Sci; 2021 Jun; 361(6):683-689. PubMed ID: 33705721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCG Vaccination Program Mitigates COVID19 Related Mortality: A Reality Check.
    Pandita A; Bhat A; Koul A; Singh SK
    Curr Pharm Biotechnol; 2021; 22(12):1574-1583. PubMed ID: 33530904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-target effects of bacillus Calmette-Guérin vaccination on immune responses to SARS-CoV-2: implications for protection against severe COVID-19.
    Messina NL; Germano S; McElroy R; Rudraraju R; Bonnici R; Pittet LF; Neeland MR; Nicholson S; Subbarao K; Curtis N;
    Clin Transl Immunology; 2022; 11(4):e1387. PubMed ID: 35573165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian rhythm influences induction of trained immunity by BCG vaccination.
    de Bree LCJ; Mourits VP; Koeken VA; Moorlag SJ; Janssen R; Folkman L; Barreca D; Krausgruber T; Fife-Gernedl V; Novakovic B; Arts RJ; Dijkstra H; Lemmers H; Bock C; Joosten LA; van Crevel R; Benn CS; Netea MG
    J Clin Invest; 2020 Oct; 130(10):5603-5617. PubMed ID: 32692732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between presence of Bacillus Calmette-Guerin vaccine scar and coronavirus disease 2019.
    Caliskaner Ozturk B; Vardaloglu I; Ongel Harbiyeli D; Gungordu N; Senkardesler G; Aliyeva N; Ismayilova A; Can G; Balkan II; Gemicioglu B; Borekci S
    Medicine (Baltimore); 2022 Dec; 101(48):e32185. PubMed ID: 36482635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum: ACTIVATE-2: A double-blind randomized trial of BCG vaccination against COVID-19 in individuals at risk.
    Tsilika M; Taks E; Dolianitis K; Kotsaki A; Leventogiannis K; Damoulari C; Kostoula M; Paneta M; Adamis G; Papanikolaou I; Stamatelopoulos K; Bolanou A; Katsaros K; Delavinia C; Perdios I; Pandi A; Tsiakos K; Proios N; Kalogianni E; Delis I; Skliros E; Akinosoglou K; Perdikouli A; Poulakou G; Milionis H; Athanassopoulou E; Kalpaki E; Efstratiou L; Perraki V; Papadopoulos A; Netea MG; Giamarellos-Bourboulis EJ
    Front Immunol; 2022; 13():1018384. PubMed ID: 36119100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between Bacillus Calmette Guerin Vaccination Policy and Coronavirus Disease-2019 (COVID-19) Incidence.
    Alyasin S; Kanannejad Z; Esmaeilzadeh H; Nabavizadeh H; Ghatee MA; Amin R
    Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):106-113. PubMed ID: 33639625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severity of COVID-19 in bacillus Calmette-Guérin vaccinated population.
    Khanum I; Kumar L; Awan S; Jamil B
    Clin Exp Vaccine Res; 2021 Sep; 10(3):276-281. PubMed ID: 34703811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.